PharmaLectures.com

Courses › Pharma training by role › Pharmacovigilance and medical: the ten documents and systems you will live in

Pharmacovigilance and medical: the ten documents and systems you will live in

Your safety files stand up in an inspection, so the launch date stays where you put it.

  • 5 audio modulesthree lengths each
  • 50 min to 4 h 10 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Pharmacovigilance and medicalwho it is written for

Why this training matters

The inspector asks for the Risk Management Plan and your team hands over an outdated draft. Nobody knows which master file annex holds the current safety contacts. The inspection stalls, a finding goes on record, and a month goes to repairs instead of the launch.

What changes after this course

Your team files each safety document the way Good Pharmacovigilance Practices (GVP) expect, and answers the inspector from the page in front of them. You hold a certificate for every learner and a training record for every person on the team.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

An inspector asks for the Pharmacovigilance System Master File, and your team opens it at the right section. Roles, responsibilities and system descriptions sit where Good Pharmacovigilance Practices (GVP) Module II puts them, and the performance and audit records are current. Nobody rings round the building to find who owns which part.

Individual Case Safety Reports stop piling up in the queue. Your specialists check the four minimum criteria, apply the International Council for Harmonisation (ICH) E2A definitions and GVP Module VI, and send the case in E2B format to EudraVigilance inside fifteen days when it is serious. Data errors get caught before transmission, not after the rejection.

Risk Management Plans and Periodic Safety Update Reports stop going back and forth with the assessor. Your regulatory staff write the plan to GVP Module V, with its Annexes in order, and the periodic report to GVP Module VII and ICH E2C(R2), with the benefit-risk conclusion stated plainly. Each detected signal goes to the right place: the report or its own procedure.

Medical information requests stop being a blind spot. A question that mentions a rash is logged, traced and passed to pharmacovigilance the day it arrives. In a trial, your team reports a suspected unexpected serious adverse reaction under European Union Regulation No 536/2014 and ICH E2A on the right clock, and reads the Clinical Study Report for the overall safety picture.

Who needs this training

  • Pharmacovigilance Officer

    A serious case arrives late on a Thursday. You check the four minimum criteria, set day zero and classify it under GVP Module VI, with no three-hour debate over causality.

  • Regulatory Affairs Associate

    You are drafting the Risk Management Plan for a launch. Each section follows GVP Module V, so the assessor stops sending questions about where a risk and its measure are described.

  • Clinical Safety Coordinator

    A suspected unexpected serious adverse reaction comes in from a trial site. You know whether the seven-day or fifteen-day report applies and who must receive it before the clock runs out.

  • Pharmacovigilance Manager

    An auditor asks for the Pharmacovigilance System Master File. You open it, find the annexes in place and the Qualified Person's details current, and hand it across the table.

  • Medical Information Specialist

    A caller describes a side effect while asking about dosing. You log the request, spot the adverse event and pass it to pharmacovigilance with the details the safety team needs.

Roles: Pharmacovigilance and medical

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: any jurisdiction

Courses are in English. Other languages on request.

After this course your people can

  1. Arrange the Pharmacovigilance System Master File in the sections GVP Module II names, with a named owner for each section.
  2. Check a report against the four minimum criteria and classify the case using ICH E2A definitions and GVP Module VI.
  3. Draft a Risk Management Plan in which each identified risk links to a measure, following GVP Module V.
  4. Assemble a Periodic Safety Update Report with a stated benefit-risk conclusion under GVP Module VII and ICH E2C(R2).
  5. Log a medical information request so that any adverse event inside it reaches pharmacovigilance and the record can be traced.
  6. Decide whether a suspected unexpected serious adverse reaction needs the seven-day or the fifteen-day report under European Union clinical trial rules.

What the company gets

  • Your Pharmacovigilance System Master File stays ready for inspection, because each section has a named owner who knows what belongs in it.
  • Your safety team sends serious cases to EudraVigilance on time, so late reporting stops being a finding waiting to happen.
  • Regulators read your Risk Management Plans and periodic reports in a structure they recognise, which cuts the rounds of questions before a decision.
  • Your trials keep running because suspected unexpected serious adverse reactions reach the authorities inside the clock that European Union rules set.
  • Each learner leaves with a certificate and a per-person training record, ready to hand to an inspector.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 5 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing50 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 05 min25 min a module, for regulatory, quality and business-development staff
Expanded4 h 10 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Pharmacovigilance and medicalStandard2 h 05 min

Course outline: 5 modules

5 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Structure the Pharmacovigilance System Master File to GVP Module II

    • How to lay out the master file so an inspector finds the answer in the section Module II names for it.
    • What to do when your Qualified Person for Pharmacovigilance leaves, so the file always names the current one.
    • The performance indicators and audit records that prove to an inspector your system works.
  2. 2Process Individual Case Safety Reports to meet GVP Module VI

    • Why a report missing one of the four minimum criteria is not yet a valid case, and what you do next.
    • How to set day zero for a serious case, so the 15-day EudraVigilance deadline is never in doubt.
    • The way to judge causality and expectedness against the product information so no query comes back.
  3. 3Write Risk Management Plans that satisfy GVP Module V

    • How to build the Risk Management Plan so an assessor finds each safety concern beside its measure.
    • What to do when a new risk emerges and the plan needs an update before the next submission.
    • When a risk needs additional risk minimisation measures and when routine ones are enough.
  4. 4Draft Periodic Safety Update Reports ready for regulatory submission

    • How to show the benefit-risk balance over the reporting interval so the assessor reaches your conclusion.
    • When a detected signal belongs in the periodic report and when it needs its own signal procedure.
    • The cumulative data to gather before the data lock point, so the report is not rewritten at the end.
  5. 5Handle Medical Information and meet Clinical Trial Safety reporting duties

    • How to log a medical information request so the adverse event hidden inside it reaches safety.
    • What to look for in a Clinical Study Report when you judge the overall safety picture.
    • Which suspected unexpected serious reactions need the seven-day report, and which the fifteen-day one.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

5 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 50 min in the briefing length and 4 h 10 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Pharmacovigilance and medical. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 45 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team